Clinical trial
Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated…
NCT00331253 · Opto Eletronica S.A., Industry · Unknown status
Key facts
| NCT number | NCT00331253 |
|---|---|
| Title | Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated Photothrombosis (i-MP). |
| Official title | A 54-WEEK, PHASE 2, MULTICENTER, MASKED, RANDOMIZED, CONTROLLED TRIAL TO ESTABLISH THE SAFETY AND EFFICACY OF INDOCYANINE GREEN-MEDIATED PHOTOTHROMBOSIS (i-MP) FOR THE TREATMENT OF PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. |
| Lead sponsor | Opto Eletronica S.A., Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Maculopathy, Age-Related |
| Intervention type | Procedure |
| Interventions | Indocyanine Green-Mediated Photothrombosis |
| Enrollment | 280 |
| Start date | Apr 1, 2007 |
| Completion | Dec 1, 2008 |
| First posted | May 29, 2006 |
| Last update posted | Apr 27, 2007 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: